Prescription medicine
Olive oil and soybean oil Brand names: Clinolipid
Olive oil and soybean oil (Clinolipid) is a prescription medicine with an FDA approval on record since 2013. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the olive oil and soybean oil FDA label on DailyMed (effective July 24, 2025, Baxter Healthcare Corporation); the NDA 204508 record on Drugs@FDA; every olive oil and soybean oil label on DailyMed.
Highlights of the record
FDA label of July 24, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageCLINOLIPID is indicated in adults and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Forms and strengths
- 16 g/100ml / 4 g/100ml
Injection (emulsion).
On the market
- Earliest approval on file
- October 3, 2013 Clinolipid 20%, Baxter Hlthcare Corp; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 29 through July 30, 2026
What is olive oil and soybean oil used for?
From the label: indications and usageCLINOLIPID is indicated in adults and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated. CLINOLIPID is indicated in adults and pediatric patients, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.
FDA pharmacologic class: Lipid Emulsion.
Source: FDA drug label (Clinolipid), Baxter Healthcare Corporation, effective July 24, 2025 (SPL set ae98eb03-c0e7-49d1-b024-77968e3d9d6e), via openFDA; the full label on DailyMed
Is there a generic for olive oil and soybean oil (Clinolipid)?
No generic olive oil and soybean oil is approved (Drugs@FDA, October 8, 2026).
- 2013 earliest approval on file
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What does the olive oil and soybean oil label say about other medicines?
The olive oil and soybean oil label names 2 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Thiamine | warnings and precautions | Thiamine deficiency and fluid retention may also develop. |
| Warfarin | drug interactions | Olive and soybean oils have a natural content of Vitamin K 1 that may counteract the anticoagulant activity of coumadin derivatives, including warfarin. |
Source: FDA drug label (Clinolipid), Baxter Healthcare Corporation, effective July 24, 2025 (SPL set ae98eb03-c0e7-49d1-b024-77968e3d9d6e), via openFDA; the full label on DailyMed
What do FAERS reports show for olive oil and soybean oil?
The FDA Adverse Event Reporting System holds 29 reports that list olive oil and soybean oil among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 5 are coded as a death and 3 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other lipid emulsions
- the pharmacologic class, with prices and generics
- Olive oil and soybean oil side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other